US GDP Grew at 2 Annual Rate in First Quarter Signaling Economic Resilience Suzlon Energy Surges as Deliveries Improve Q4 Revenue Jumps 45 DoubleDigit Earnings Growth May Not Prevent the Next Bear Market History Suggests GitHubs Reliability Woes Threaten Microsofts AI Coding Leadership Amid Rising Competition Plus500 Revenue Climbs 11 in Latest Quarter Company Confirms Guidance Shark Attack Incident Off Cassowary Coast May Influence Queensland Tourism Sector Phoenix New Media Q3 2024 Earnings WiderThanExpected Loss Amid Revenue Uncertainty Unisys Q1 2026 Earnings EPS Surges Past Expectations Despite Net Loss AVBH Q1 2026 Earnings EPS Surpasses Estimates by 275 Stock Slightly Declines AUGO Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines SXT Q1 2026 Earnings EPS Surges Past Estimates by 22 Shares Edge Higher Tompkins Financial Corporation TMP Q1 2026 Earnings EPS Beat of 277 Amid Steady Operating Performance Amerant Bancorp Inc AMTB Rallies 174 as Buyers Test Resistance Near 24 TriplePoint Venture Growth BDC TPVG Slips 21 as Pressure Mounts Near Key Support Armata Pharmaceuticals ARMP Edges Higher Stock Holds Near Key Resistance After Modest Gain SOLV Energy Inc MWH Slides 35 Support Test Ahead as Resistance Holds Roivant Sciences ROIV Edges Lower Amid Consolidation Near Resistance Levels Enphase Energy Shares Surge 137 Following Goldman Sachs Optimistic Outlook Trainline Raises Guidance for Second Time This Year LRS Outflows Surge Over 10 in March 2026 as Travel Demand and Investments Drive Capital Abroad Saudi Arabias Vision 2030 Spending Spree Meets Fiscal Reality SEBI Bars Seven Family Members for Social Media Stock Manipulation Alleges 2025 Crore Illegal Gains Pentagon UFO Files Renew Public Interest in Alien Theories What It Means for Defense and Aerospace Sectors Ryan Cohen Eyes eBay Acquisition with GameStops Balance Sheet Firepower BuzzFeed Inc BZFD Q1 2026 Earnings EPS Misses Estimates as Stock Surprises with Rally Rezolve AI Warrants RZLVW Edge Higher Navigating Support and Resistance Levels ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development ZVIA Q1 2026 Earnings NarrowerThanExpected Loss Drives DoubleDigit Stock Gain PAYC Q1 2026 Earnings EPS Beat Drives Cautious Sentiment TRVI Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Shares Edge Higher MBRX Q1 2026 Earnings EPS Misses Estimates as Development Costs Rise SIG Q1 2026 Earnings EPS Beats Estimates as Profitability Shines Stock Edges Down